Fact CheckerSign in

NCT06552403Completed

Effect of a Modified 5:2 Intermittent Fasting Diet on Population With Overweight or Obesity in China

Effect of a Modified 5:2 Intermittent Fasting Diet on Population With Overweight or Obesity in China: A Self-controlled Clinical Trial

Source: ClinicalTrials.gov · Last updated 14 Aug 2024

Brief summary (registry, in English)

This study aimed to investigate the effects of the modified 5:2 IF dietary intervention on the Chinese population with overweight or obesity based on a self-controlled clinical trial.

Status (registry)
Completed
Study type
Interventional
Enrollment
45 (actual)
First submitted
31 Jul 2024
Start date
1 Jan 2022
Primary completion date
31 Dec 2023
Lead sponsor
Zhejiang Provincial Tongde Hospital
Diseases
Obesity
NCT number
NCT06552403

What you commit to

  • Study type: Interventional
  • Participants enrolled: 45
  • From 1 Jan 2022 to the primary completion date, 31 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • participants taking any medication with an effect on body weight in the three months prior to enrollment;

Other illness

  • participants with a history of cardiovascular disease (e.g., coronary heart disease, stroke);
  • participants with malignant tumors;

Lab values

  • participants with liver or kidney dysfunction (liver enzymes ≥ 2 times normal; blood creatinine \> the upper limit of normal);

Other

  • women during pregnancy or breastfeeding;
  • participants deemed unsuitable by the investigator to participate in this trial.

Who the study is looking for

  • participants aged 18 to 60 years
  • participants with a body mass index (BMI) ≥ 24 kg/m2
  • participants engaged in light physical labor and their weight was relatively stable.

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Xiaoli Wang
Coordinator of this site? Confirm its status
HangzhouChinaUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.